Wordt geladen...
Diffuse Hypopigmentation Followed by Hyperpigmentation in an African American Woman with Hemangiopericytoma Treated with Dasatinib
Dasatinib is a second-generation multi-target tyrosine kinase inhibitor (TKI) that has activity against many imatinib-resistant BCR-ABL mutant forms, Src, and c-Kit tyrosine kinases. While skin hypopigmentation is a well recognized adverse effect of first generation TKIs; it has rarely been reported...
Bewaard in:
| Gepubliceerd in: | J Clin Diagn Res |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
JCDR Research and Publications (P) Limited
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4290303/ https://ncbi.nlm.nih.gov/pubmed/25584281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2014/8055.5160 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|